David C. Morrison

Editorial
J Endotoxin Res 1995 2: 149-150. [PDF] [References]  

R.C. Bone

Sepsis and the systemic inflammatory response syndrome (SIRS)
J Endotoxin Res 1995 2: 151-155. [PDF] [References]  

C.A. Dinarello

Blocking interleukin-1 in sepsis
J Endotoxin Res 1995 2: 157-162. [Abstract] [PDF] [References]  

R. Rabinovici, L.F. Neville, and G. Feuerstein

Current understanding of sepsis: criticism and a proposal
J Endotoxin Res 1995 2: 163-168. [Abstract] [PDF] [References]  

W.A. Knaus, D.P. Wagner, X. Sun, F.E. Harrell, JR, and J.S. Hedstrom

Risk assessment in recent clinical trials in sepsis/SIRS: lessons learned and future directions
J Endotoxin Res 1995 2: 169-175. [Abstract] [PDF] [References]  

J.H. Siegel, D. Rixen, and H.P. Friedman

Physiological classification and stratification of illness severity of posttrauma 'sepsis' patients as a basis for randomization of clinical trials
J Endotoxin Res 1995 2: 177-188. [PDF] [References]  

G.Z. Feuerstein, L.F. Neville, and R. Rabinovici

Pulmonary TNF is a critical mediator in Adult Respiratory Distress Syndrome
J Endotoxin Res 1995 2: 189-193. [Abstract] [PDF] [References]  

T. Hartung, H-D. Volk, and A. Wendel

G-CSF - an anti-inflammatory cytokine
J Endotoxin Res 1995 2: 195-201. [Abstract] [PDF] [References]  

D.L. Williams, A. Mueller, and W. Browder

Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae
J Endotoxin Res 1995 2: 203-208. [Abstract] [PDF] [References]  

J. Au-Young, J.J. Seilhamer, L. Lin, B.M. McKelligon, J.C. Lane, J.L. Snable, M.T. Kikuchi, R.W. Scott, and M.N. Marra

A novel LBP-BPI fusion protein with in vivo efficacy and longer half life
J Endotoxin Res 1995 2: 209-212. [Abstract] [PDF] [References]  

D.J. Rechtman

MPL®-S to reduce the risk of infection and its sequelae
J Endotoxin Res 1995 2: 213-216. [PDF] [References]  

P.J. Scannon

Applying lessons learned from anti-endotoxin therapy
J Endotoxin Res 1995 2: 217-220. [PDF] [References]  

S.M. Opal

Lessons learned from clinical trials of sepsis
J Endotoxin Res 1995 2: 221-226. [Abstract] [PDF] [References]  

C.J. Fisher, JR

Can second-generation versions of existing therapeutics be successful in clinical trials of sepsis?
J Endotoxin Res 1995 2: 227-232. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.